Aave (AAVE), Pullix (PLX), and Injective (INJ) have all emerged as promising altcoins. With each coin’s unique strengths, investors debate which one will outshine the rest. According to some experts, Pullix, which is now in Stage 5 of its presale, could reach new highs as it becomes a 100x token in 2024. Let’s find out why.
Aave News
Aave (AAVE) recently released the V3 version of Aave Governance, built by bgdlabs. In Governance v3, three AAVE tokens hold voting power: AAVE, stkAAVE, and AAVE deposited on Aave v3 Ethereum. The Aave coin trading price increased from $100.42 on December 26 to $121.86 on December 28.
From a technical perspective, this bullish trend may continue as 26 technical indicators show green for Aave. Moreover, AAVE is trading above its 50 and 100-day EMAs – good bullish signs.
As a result, CoinCodex analysts predict that Aave could trade at the $128 level in January 2024. This makes it one of the altcoins to watch.
Pullix (PLX): A Future Top 5 Cryptocurrency
Pullix (PLX) is a new DeFi project which brings a hybrid exchange that combines CEX and DEX strengths. This revolutionary platform aims to address known challenges in the online trading sector. While many exchanges like Binance only offer cryptocurrency trading, Pullix stands out by facilitating the exchange of all asset classes (including cryptos) – bringing convenience and accessibility.
While this exchange is the main attraction of this DeFi project, the Pullix team will also bring other components into its ecosystem:
- VaultX: It is a cross-chain yield optimizer, empowering users to compound their crypto assets and accrue interest.
- Yield Farming: A feature that allows you to earn PLX tokens through LP Token staking.
- Copy Trading: This feature allows you to copy trades from successful traders and capitalize off of their choices.
Its native token, PLX, fuels all these features. This token serves as the cornerstone of the platform, driving transactions and empowering holders. By holding it, you will receive discounts on trading fees and exclusive asset access. With its “Trade-to-Earn” model, staking will bring you a percentage of Pullix’s daily revenue. If you wish to become a liquidity provider, you may even stake other cryptos with Pullix for a fixed interest rate.
These passive income capabilities have triggered a frenzy in the crypto community. With over 45M PLX tokens sold and $2M raised, demand for this token is sky-high. One PLX token is currently worth $0.07 – a 70% increase from its starting price. However, it is in Stage 5 of its presale, and as it advances – more price pumps will occur.
Thanks to its ties to the OTC derivatives market, which was valued at $618T in 2022 as per ISDA, Pullix’s long-term growth potential is outstanding. Experts foresee a 580% price increase before its presale ends and another 100x growth after a Tier-1 CEX lists it in Q1 of 2024. Sign up for this altcoin’s presale below to capitalize on this growth.
Injective (INJ): One of the Altcoins To Buy
Meanwhile, Injective (INJ) recently announced its proposal 302, which aims to burn the revenue generated from INJ domain names. In terms of the Injective coin value movement, it jumped from $16.09 on November 28 to $37.64 on December 28.
The technical analysis of this altcoin also paints a bullish picture, as 24 technical indicators are showing green. Furthermore, Injective recorded 16/30 (53%) green trading days over the last month alone.
Due to all these reasons, experts foresee the Injective crypto trading at $38.84 in January 2024.
In Closing
All of these altcoins possess distinct attributes that could lead to ATHs. However, Pullix stands out thanks to its low market cap of $9.2M. To clarify, Aave and Injective have market caps of $1.7B and $3.1B, meaning they would need many new funds to experience price growth. But Pullix will not have this problem – plus, it only needs $9.2M for its price (and returns) to double. Therefore, PLX will reach its ATH first.
For more information regarding Pullix’s presale see links below:
